Evidence map›Paper›PMID 33169762›Full record

ReviewNatural product reports2020

The quest for supernatural products: the impact of total synthesis in complex natural products medicinal chemistry.

Zhi-Chen Wu, Dale L Boger

Abstract readReview
In one paragraph

Review in Natural product reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.

0numbers the graph read from it
0cells of the map it votes in
20citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

20 citing papers in PubMed.

  1. Article
  2. Article
  3. Supernatural Products.The Chemist · 2025
    Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
  11. Article
  12. Total synthesis: an enabling science.Beilstein journal of organic chemistry · 2023
    Article
  13. Article
  14. Article
  15. Review
  16. Total Synthesis of Bipolamine I.Journal of the American Chemical Society · 2022
    Article
  17. Article
  18. Late-Stage Diversification: A Motivating Force in Organic Synthesis.Journal of the American Chemical Society · 2021
    Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Zhi-Chen WuDepartment of Chemistry, The Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 N. Torrey Pines Road, La Jolla, CA 92037, USA. dale.boger@outlook.com.
Dale L Boger

Funding

ANTITUMORE ANTIBIOTICS: STREPTONIGRIN AND LAVENDAMYCINR01CA042056 · NCI · SCRIPPS RESEARCH INSTITUTE, THE · PI BOGER, DALE L · 1985 to 2024
$10.6M
LUZOPEPTINS, VANCOMYCIN AND RELATED AGENTSR01CA041101 · NCI · SCRIPPS RESEARCH INSTITUTE, THE · PI BOGER, DALE L · 1985 to 2024
$9.5M
Modulating Signaling Endocannabinoids and Fatty Acid AmidesR37DA015648 · NIDA · SCRIPPS RESEARCH INSTITUTE, THE · PI DALE L BOGER · 2018 to 2026
$3.8M
Modulating Signaling Endocannabinoids and Fatty Acid AmidesR01DA015648 · NIDA · SCRIPPS RESEARCH INSTITUTE, THE · PI BOGER, DALE L · 2002 to 2017
$3.7M
A Unique Class of Reductively Activated Oncology DrugsR01CA208669 · NCI · SCRIPPS RESEARCH INSTITUTE, THE · PI BOGER, DALE L, FELDING, BRUNIE H. · 2017 to 2021
$3.6M
NCI NIH HHS R01 CA041101NCI NIH HHS R01 CA042056NCI NIH HHS R01 CA208669NIDA NIH HHS R01 DA015648NIDA NIH HHS R37 DA015648
6 · The paper itself

Abstract

Covering: 2000 up to 2020This review presents select recent advances in the medicinal chemistry of complex natural products that are prepared by total synthesis. The underlying studies highlight enabling divergent synthetic strategies and methods that permit the systematic medicinal chemistry studies of key analogues bearing deep-seated structural changes not readily accessible by semisynthetic or biosynthetic means. Select and recent examples are detailed where the key structural changes are designed to improve defined properties or to overcome an intrinsic limitation of the natural product itself. In the examples presented, the synthetic efforts provided supernatural products, a term first introduced by our colleague Ryan Shenvi (Synlett, 2016, 27, 1145-1164), with properties superseding the parent natural product. The design principles and approaches for creating the supernatural products are highlighted with an emphasis on the properties addressed that include those that improve activity or potency, increase selectivity, enhance durability, broaden the spectrum of activity, improve chemical or metabolic stability, overcome limiting physical properties, add mechanisms of action, enhance PK properties, overcome drug resistance, and/or improve in vivo efficacy. Some such improvements may be regarded by some as iterative enhancements whereas others, we believe, truly live up to their characterization as supernatural products. Most such efforts are also accompanied by advances in synthetic organic chemistry, inspiring the development of new synthetic methodology and providing supernatural products with improved synthetic accessibility.

Indexed as

Chemistry, PharmaceuticalAnti-Bacterial AgentsAntineoplastic AgentsBiological ProductsDrug DiscoveryStructure-Activity RelationshipAnti-Bacterial AgentsAntineoplastic AgentsBiological Products

Identifiers

PMID33169762
PMCPMC7678878

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.